Studying social interaction in schizophrenia
Part of Mental health clinical trials.
This trial looks at how people with schizophrenia and healthy volunteers synchronize during conversations. It aims to understand social difficulties in schizophrenia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia according to standard criteria
- You can read, speak, and understand French
- You are willing to provide informed consent
- You have no history of head injury, neurological conditions, or substance use
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how people with schizophrenia and healthy volunteers track sources of information using a French computer task. It may help researchers better understand memory and thinking differences that could guide future support and treatments.
This study looks at how brain signals relate to social thinking in people with schizophrenia or schizoaffective disorder. The goal is to better understand the condition and identify what might improve social functioning.
This study looks at brain signals and behavioral measures to understand empathy-related processes in people with schizophrenia or schizoaffective disorder. It may help researchers better understand what’s happening in the brain and how it relates to feelings and social understanding.
This trial asks people who have schizophrenia to share their experience doing study activities, and it tests whether the study procedures work well for patients. It may help improve how future schizophrenia studies are run.
This study looks at how language and memory interact in people with psychosis, including those at risk, early psychosis, or schizophrenia, as well as healthy volunteers. It aims to understand these connections better, which may help improve care.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.